FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 4.0.7  |  FHIR Version n/a  User: [n/a]

12880611000001109: Salbutamol 2.5mg/2.5ml nebuliser liquid unit dose vials (Kent Pharma (UK) Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Apr 2008. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1864181000001118 Salbutamol 2.5mg/2.5ml nebuliser liquid unit dose vials (Kent Pharma (UK) Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1864191000001116 Salbutamol 2.5mg/2.5ml nebuliser liquid unit dose vials (Kent Pharma (UK) Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
45267601000001116 Salbutamol 1mg/ml nebuliser liquid 2.5ml unit dose vials (Kent Pharmaceuticals Ltd) (product) en Fully specified name Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module
45267701000001114 Salbutamol 1mg/ml nebuliser liquid 2.5ml unit dose vials (Kent Pharmaceuticals Ltd) en Synonym Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module
58646001000001119 Salbutamol 2.5mg/2.5ml nebuliser liquid unit dose vials (Kent Pharmaceuticals Ltd) en Synonym Inactive Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Salbutamol 2.5mg/2.5ml nebuliser liquid unit dose vials (Kent Pharma (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Salbutamol 2.5mg/2.5ml nebuliser liquid unit dose vials (Kent Pharma (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Salbutamol 2.5mg/2.5ml nebuliser liquid unit dose vials (Kent Pharma (UK) Ltd) Is a Salbutamol 2.5mg/2.5ml nebuliser liquid unit dose vials true Inferred relationship Existential restriction modifier
Salbutamol 2.5mg/2.5ml nebuliser liquid unit dose vials (Kent Pharma (UK) Ltd) Is a Salbutamol 2.5mg/2.5ml nebuliser liquid unit dose vials false Inferred relationship Existential restriction modifier
Salbutamol 2.5mg/2.5ml nebuliser liquid unit dose vials (Kent Pharma (UK) Ltd) Has dispensed dose form Nebuliser liquid false Inferred relationship Existential restriction modifier
Salbutamol 2.5mg/2.5ml nebuliser liquid unit dose vials (Kent Pharma (UK) Ltd) Has dispensed dose form Nebuliser liquid true Inferred relationship Existential restriction modifier
Salbutamol 2.5mg/2.5ml nebuliser liquid unit dose vials (Kent Pharma (UK) Ltd) Is a Salbutamol 2.5mg/2.5mL nebulization unit false Inferred relationship Existential restriction modifier
Salbutamol 2.5mg/2.5ml nebuliser liquid unit dose vials (Kent Pharma (UK) Ltd) Has active ingredient Salbutamol sulfate false Inferred relationship Existential restriction modifier
Salbutamol 2.5mg/2.5ml nebuliser liquid unit dose vials (Kent Pharma (UK) Ltd) Has active ingredient Salbutamol true Inferred relationship Existential restriction modifier
Salbutamol 2.5mg/2.5ml nebuliser liquid unit dose vials (Kent Pharma (UK) Ltd) Has manufactured dose form Nebulizer liquid false Inferred relationship Existential restriction modifier
Salbutamol 2.5mg/2.5ml nebuliser liquid unit dose vials (Kent Pharma (UK) Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Salbutamol 2.5mg/2.5ml nebuliser liquid unit dose vials (Kent Pharma (UK) Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Salbutamol 2.5mg/2.5ml nebuliser liquid unit dose vials (Kent Pharma (UK) Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Salbutamol 2.5mg/2.5ml nebuliser liquid unit dose vials (Kent Pharma (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Salbutamol true Inferred relationship Existential restriction modifier
Salbutamol 2.5mg/2.5ml nebuliser liquid unit dose vials (Kent Pharma (UK) Ltd) Has specific active ingredient Salbutamol sulfate true Inferred relationship Existential restriction modifier
Salbutamol 2.5mg/2.5ml nebuliser liquid unit dose vials (Kent Pharma (UK) Ltd) Has dispensed dose form Nebulizer liquid false Inferred relationship Existential restriction modifier
Salbutamol 2.5mg/2.5ml nebuliser liquid unit dose vials (Kent Pharma (UK) Ltd) Has manufactured dose form Inhalation dosage form false Inferred relationship Existential restriction modifier
Salbutamol 2.5mg/2.5ml nebuliser liquid unit dose vials (Kent Pharma (UK) Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Salbutamol 2.5mg/2.5ml nebuliser liquid unit dose vials (Kent Pharma (UK) Ltd) Has basis of strength substance Salbutamol true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Salbutamol 2.5mg/2.5ml nebuliser liquid unit dose vials (Kent Pharma (UK) Ltd) 20 unit dose Is pack of False Salbutamol 2.5mg/2.5ml nebuliser liquid unit dose vials (Kent Pharma (UK) Ltd) Inferred relationship Existential restriction modifier
Salbutamol 2.5mg/2.5ml nebuliser liquid unit dose vials (Kent Pharma (UK) Ltd) 20 unit dose Has AMP True Salbutamol 2.5mg/2.5ml nebuliser liquid unit dose vials (Kent Pharma (UK) Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start